Tag Archives: NAFLD

Endotoxin Antagonists Part V

Content Guide. Part I Part II Part III Part IV

A look at some pre and pro-biotics in endotoxemia or related inflammation.
Prebiotics:
Galacto-oligoaccharides (GOS):

A Mixture of trans-Galactooligosaccharides Reduces Markers of Metabolic Syndrome and Modulates the Fecal Microbiota and Immune Function of Overweight Adults
GOS can increase bifido bacteria, which is often correlated with lowering endotoxin.… More

Biocast Episode 010 Endotoxin Obesity and Diabetes in Humans


Download
Back with another episode of The Biocast. This episode looks at the evidence for endotoxin in causing obesity and type II diabetes in humans.
The topic is also closely tied into liver conditions like NAFLD and NASH and potentially any other chronic inflammatory condition.
More

Biocast Episode 009 – Endotoxin, Obesity and Diabetes

Episode 9 looks at a cause of obesity and diabetes: endotoxin, or lipopolysaccharide. There will be at least one more podcast on the topic, but this one looks at a number of rodent studies creating diabetes, obesity and other markers of the metabolic syndrome.More